Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (3052)	12/2/1997 8:52:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 6136

David, I do recall your comments on Thymitaq. However, as recently as yesterday, Jim McCamant was commenting positively on AGPH's MMPI program. Do you have any comments on this program?

To: David S. who wrote (3052)	12/2/1997 9:12:00 AM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Well, John has said we'd hear news soon on Thymitaq. I understand now why the visible analyst support may have dried up. We'll have to see how they handle this one. With the right comments the analysts/company could bail out of this gracefully...we'll see. Looks like we're a one drug company for some time to come? Joe Kernon has been handling the situation delicately, suggesting there's a school of thought that would view this as a positive by facing the facts and cutting any further losses. From now on I keep my wishfull thinking to myself. sf

To: David S. who wrote (3052)	12/2/1997 10:54:00 AM
From: Peter Church	Read Replies (2) \| Respond to of 6136

This is really sad, after I finally learned how to spell it, Thymitak turns out a dud. I can't remember that you posted anything about Thymitac. Did you really?

To: David S. who wrote (3052)	12/2/1997 11:39:00 AM
From: Joe E.	Read Replies (1) \| Respond to of 6136

<<Gee, I wonder if there were any people who gave a warning MONTHS ago that Thymitaq was garbage? It is interesting that those who claimed be be the closest to AGPH management were always the most bullish regarding Thymitaq. Does that say anything about credibility?>> David, I will agree you warned me (and I suppose others) on this thread that Thymitaq was not a world beater. i do not recall anything about garbage, though. From the results revealed so far, it looks to me like Thymitaq might have potential with radiation, but it is apparently just too expensive to find out. I think there may be an opportunity for another company to get the rights to the drug and develop it into something good. Still, I have to say you were right.